Acute Transplant Rejection Rate Lower with Alemtuzumab Renal and Urology News CHICAGO—Alemtuzumab use is associated with a lower incidence of acute rejection and infection compared to rabbit anti-thymocyte globulin (rATG) induction in kidney and pancreas transplant recipients, regardless of age or ethnicity, according to a new ... |
